Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Axelrod Potter, M.D.

Concepts (65)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fetal Death120234340.760 Why?
Abortion, Induced120234600.580 Why?
Fragile X Syndrome320201160.460 Why?
Dilatation220233070.240 Why?
Philadelphia Chromosome120221170.200 Why?
Antiemetics120221870.180 Why?
Pregnancy Trimester, Second120237320.180 Why?
Language Therapy12020250.180 Why?
Lovastatin120201160.170 Why?
GABA Agonists120191050.160 Why?
Education, Medical, Undergraduate1202310660.110 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1202215470.110 Why?
Gene Silencing1201915130.100 Why?
Metformin120199120.100 Why?
Hemorrhage1202336000.090 Why?
Education, Medical1202317270.090 Why?
Mothers1202021860.080 Why?
Molecular Targeted Therapy1201928030.070 Why?
Hypoglycemic Agents1201931500.070 Why?
Pregnancy22023297490.060 Why?
Carcinoma, Non-Small-Cell Lung1202252510.050 Why?
Antineoplastic Combined Chemotherapy Protocols12022117120.050 Why?
Gene Expression Regulation12019119030.050 Why?
Pyridazines120222000.040 Why?
Cohort Studies12023413350.040 Why?
Clinical Trials, Phase I as Topic120223260.040 Why?
Doxycycline120223410.040 Why?
Proto-Oncogene Proteins c-ret120222250.040 Why?
Retrospective Studies32023803720.040 Why?
Telecommunications12020800.040 Why?
Vincristine1202210390.040 Why?
Clinical Trials, Phase II as Topic120226290.040 Why?
Vomiting120226500.040 Why?
Fragile X Mental Retardation Protein120191160.040 Why?
Lung Neoplasms12022132620.040 Why?
Cyclophosphamide1202222210.030 Why?
Imidazoles1202211800.030 Why?
California1202014160.030 Why?
Doxorubicin1202222090.030 Why?
Dexamethasone1202219270.030 Why?
Intubation, Intratracheal1202213280.030 Why?
Learning1202317390.030 Why?
Humans820237606210.020 Why?
Pyrazoles1202219990.020 Why?
Language1202015330.020 Why?
Pyridines1202228790.020 Why?
Female320233912700.020 Why?
Curriculum1202337180.020 Why?
Clinical Competence1202347830.020 Why?
Child32020798060.020 Why?
Double-Blind Method12020124270.020 Why?
Communication1202038490.020 Why?
Protein Kinase Inhibitors1202256430.020 Why?
Epigenesis, Genetic1201937580.020 Why?
DNA Methylation1201943730.010 Why?
Disease Models, Animal12019181370.010 Why?
Prognosis12019296580.010 Why?
Child, Preschool12019420630.010 Why?
Signal Transduction12019233760.010 Why?
Treatment Outcome12019650170.010 Why?
Adolescent12020878100.010 Why?
Male220203597440.010 Why?
Middle Aged120222203520.000 Why?
Adult120222199940.000 Why?
Animals120191679630.000 Why?
Potter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.